Involvement of innate immunity in the development of inflammatory and autoimmune diseases

Annals of the New York Academy of Sciences

Volumn 1051, Issue , 2005, Pages 787-798

  Tlaskalová Hogenová, Helena ^a,d   Tucková, Ludmila ^a   Stepánková, Renata ^a   Hudcovic, Tomás ^a   Palova Jelinkova, Lenka ^a   Kozáková, Hana ^a   Rossmann, Pavel ^a   Sanchez, Daniel ^a   Cinová, Jana ^a   Hrnĉír̂, Tomás ^a   Kverka, Miloslav ^a   Frolová, Lenka ^a   Uhlig, Holm ^b   Powrie, Fiona ^b   Bland, Paul ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

Animal models; Autoimmunity; Celiac disease; Commensal bacteria; Germ free animals; Gliadin; Gluten; Gut microbiota; Inflammation; Inflammatory bowel diseases; Innate immunity; Mucosal barrier; Mucosal immunity

Indexed keywords

DEXTRAN SULFATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CELIAC DISEASE; COMMENSALISM; CONFERENCE PAPER; CONTROLLED STUDY; GERMFREE ANIMAL; IMMUNE SYSTEM; INFLAMMATION; INNATE IMMUNITY; INTESTINE FLORA; INTESTINE MUCOSA; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PATHOGENESIS; T LYMPHOCYTE ACTIVATION;

ANIMALIA; TRITICUM AESTIVUM;

EID: 25444461358     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1361.122     Document Type: Conference Paper

References (52)

1. MESTECKY, J., M.W. RUSSEL, S. JACKSON, et al. 1995. Advances in Mucosal Immunology. Plenum Press. New York, London.
2. TLASKALOVÁ-HOGENOVÁ, H., L. TUCKOVÁ, R. LODINOVÁ-ZÁDNÍKOVÁ, et al. 2002. Mucosal immunity: its role in defense and allergy. Int. Arch. Allergy Immunol. 128: 77-89.
3. BRANDTZAEG, P. & R. PABST. 2004. Let's go mucosal: communication on slippery ground. Trends Immunol. 25: 570-577.
4. MESTECKY, J., M.E. LAMM, W. STROBER, et al. 2005. Mucosal Immunology, 3rd ed. Elsevier Academic Press. Amsterdam.
5. MEDZHITOV, R. & C. JANEWAY, JR. 2000. Innate immune recognition: mechanisms and pathways. Immunol. Rev. 173: 89-97.
6. ADEREM, A. & R.J. ULEVITCH. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406: 782-787.
7. AKIRA, S. & K. TAKEDA. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
8. FUNDA, D.P., L. TUCKOVÁ, M. FARRÉ, et al. 2001. CD14 is expressed and released as soluble CD14 by human intestinal epithelial cells in vitro: lipopolysaccharide activation of epithelial cells revisited. Inf. Immun. 69: 3772-3781.
9. BEVINS, C.L. 2004. The Paneth cell and the innate immune response. Curr. Opin. Gastroenterol. 20: 572-580.
10. TLASKALOVÁ-HOGENOVÁ, H., J. STERZL, R. STEPÁ NKOVÁ, et al. 1983. Development of immunological capacity under germfree and conventional conditions. Ann. N.Y. Acad. Sci. 409:96-113.
11. TLASKALOVÁ-HOGENOVÁ, H. 1997. Gnotobiology as a tool - an introduction. In Immunology Methods Manual. I. Lefkovits, Ed.: 1524-1559. Academic Press. London.
12. HARMSEN, H.J., G.C. RAANGS, T. HE, et al. 2002. Extensive set of 16S rRNA-bases probes for detection of bacteria in human feces. Appl. Environ. Microbiol. 68: 2982-2990.
13. HOOPER, L.V., M.H. WONG, A. THELIN, et al. 2001. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291: 881-884.
14. TLASKALOVÁ-HOGENOVÁ, H., R. STEPÁNKOVÁ, T. HUDCOVIC, et al. 2004. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immun. Lett. 93: 97-108.
15. CEBRA, J.J., H.Q. JIANG, N. BOIKO & H. TLASKALOVÁ- HOGENOVÁ. 2005. The role of mucosal microbiota in the development, maintenance, and pathologies of the mucosal immune system. In Mucosal Immunology, 3rd ed. J. Mestecky, M.E. Lamm, W. Strober, et al., Eds.: 335-368. Elsevier Academic Press. Amsterdam.
16. SINGH, B., S. READ, C. ASSEMAN, et al. 2001. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182: 190-200.
17. POWRIE, F. & H. UHLIG. 2004. Animal models of intestinal inflammation: clues to the pathogenesis of inflammatory bowel disease. Novartis Found. Symp. 263: 164-174.
18. RAKOFF-NAHOUM, S., J. PAGLINO, F. ESLAMI-VARZANEH, et al. 2004. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241.
19. FASANO, A., T. NOT, W. WANG, et al. 2000. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 355: 1518-1519.
20. FASANO, A. 2001. Intestinal zonulin: open sesame! Gut 49: 159-162.
21. NEUTRA M.P. & J.P. KRAEHENBUHL. 2005. Cellular and molecular basis for antigen transport across epithelial barriers. In Mucosal Immunology, 3rd ed. J. Mestecky, M.E. Lamm, W. Strober, et al., Eds.: 111-130. Elsevier Academic Press. Amsterdam.
22. SHOENFELD, Y. & N.R. ROSE. 2004. Infection and Autoimmunity. Elsevier. Amsterdam.
23. BACH, J.F. 2002. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347: 930-931.
24. KITA, H., X.S. HE & M.E. GERSHWIN. 2004. Autoimmunity and environmental factors in the pathogenesis of primary biliary cirrhosis. Ann. Med. 36: 72-80.
25. TOUBI, E. & Y. SHOENFELD. 2004. Toll-like receptors and their role in the development of autoimmune diseases. Autoimmunity 73: 183-188.
26. MACDONALD, T.T., G. MONTELEONE & S.L. PENDER. 2000. Recent developments in the immunology of inflammatory bowel disease. Scand. J. Immunol. 52: 2-9.
27. STROBER, W. & R.O. EHRHARDT. 1993. Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice. Cell 78: 203-295.
28. STROBER, W., I.J. FUSS & R.S. BLUMBERG. 2002. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20: 495-549.
29. ELSON, C.O., A. KONRAD, Y. CONGH, et al. 2004. Gene disruption and immunity in experimental colitis. Inflamm. Bowel Dis. 10: S25-S28.
30. SARTOR, R.B. 2005. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126: 1620-1633.
31. SARTOR, R.B. 2003. Innate immunity in the pathogenesis and therapy of IBD. J. Gastroenterol. 38 (Suppl. 15): 43-47.
32. BENDJELLOUL, F., P. MALY, V. MANDYS, et al. 2000. Intercellular adhesion molecule-1 (ICAM-1) deficiency protects mice against severe forms of experimentally induced colitis. Clin. Exp. Immunol. 119: 57-63.
33. HUDCOVIC, T., R. STEPÁNKOVÁ, J. CEBRA, et al. 2001. The role of microflora in the development of intestinal inflammation: acute and chronic colitis induced by dextran sulfate in germ-free and conventionally reared immunocompetent and immunodeficient mice. Folia Microbiol. (Praha) 46: 565-572.
34. STEPÁNKOVÁ, R., H. TLASKALOVÁ, F. POWRIE, et al. 2004. The role of segmented filamentous bacteria (SFB) in experimental colitis induced in SCID mice reconstituted with CD4+CD45RB/hight T cells [abstract]. Gut 36 (Suppl. 1): A305.
35. CUKROWSKA, B., R. LODINOVÁ-ZÁDNÍKOVÁ, C. ENDERS, et al. 2002. Specific proliferative and antibody responses of premature infants to intestinal colonization with non-pathogenic probiotic E. coli strain Nissle 1917. Scand. J. Immunol. 55: 204-209.
36. LODINOVÁ-ZÁDNÍKOVÁ, R., B. CUKROWSKA & H. TLASKALOVÁ-HOGENOVÁ. 2003. Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life. Int. Arch. Allergy Immunol. 131: 209-211.
37. KALLIOMAKI, M.A. & E. ISOLAURI. 2004. Probiotics and down-regulation of the allergic response. Immunol. Allergy Clin. North Am. 24: 739-752.
38. CUMMING, J.H., J.M. ANTOINE, E. AZPIROZ, et al. 2004. PASSCLAIM - gut health and immunity. Eur. J. Nutr. 43 (Suppl. 2): II118-II173.
39. KOZÁKOVÁ, H., Z. REHÁKOVÁ & J. KOLÍNSKÁ. 2001. Bifidobacterium bifidum monoassociation of gnotobiotic mice: effect on enterocyte brush-border enzymes. Folia Microbiol. (Praha) 46: 573-576.
40. DANESE, S., M. SANS & C. FIOCCHI. 2004. Inflammatory bowel disease: the role of environmental factors. Autoimmun. Rev. 3: 394-400.
41. STEPÁNKOVÁ, R., H. TLASKALOVÁ, J. SINKORA, et al. 1996. Changes in jejunal mucosa after long-term feeding of germfree rats with gluten. Scand. J. Gastroenterol. 31: 551-557.
42. SOLLID, L.M. 2002. Coeliac disease: dissecting a complex inflammatory disorder. Nat. Rev. Immunol. 2: 647-655.
43. SCHUPPAN, D., B. ESSLINGER & W. DIETRICH. 2003. Innate immunity and coeliac disease. Lancet 362: 3-5.
44. CERF-BENSUSSAN, N., N. BROUSSE, C. CAILLAT-ZUCMAN, et al. 2003. Coeliac Disease. John Libbey Eurotext. Esber, UK.
45. KRUPICKOVÁ, S., L. TUCKOVÁ, Z. FLEGELOVÁ, et al. 1999. Identification of common epitopes on gliadin, enterocytes, and calreticulin recognised by antigliadin antibodies of patients with celiac disease. Gut 44: 168-173.
46. ROSE, N.R. 2002. Mechanisms of autoimmunity. Semin. Liver Dis. 22: 387-394.
47. NOVÁK, P., P. MAN, L. TUCKOVÁ, et al. 2002. Monitoring of in vitro deamidation of gliadin peptic fragments by mass spectrometry may reflect one of the molecular mechanisms taking place in celiac disease development. J. Mass Spectrom. 37: 507-511.
48. TUCKOVÁ, L., H. TLASKALOVÁ-HOGENOVÁ, Z. FLEGELOVÁ, et al. 2000. Activation of macrophages by food antigens: enhancing effect of gluten on nitric oxide and cytokine production. J. Leukoc. Biol. 67: 312-318.
49. TUCKOVÁ, L., J. NOVOTNÁ, P. NOVÁK, et al. 2002. Activation of macrophages by gliadin fragments: isolation and characterization of active peptide. J. Leukoc. Biol. 71: 625-631.
50. JELÍNKOVÁ, L., L. TUCKOVÁ, J. CINOVÁ, et al. 2004. Gliadin stimulates human monocytes to production of IL-8 and TNF-γ through a mechanism involving NF-κN. FEBS Letters 571: 81-85.
51. MAIURI, M.C., D. DE STEFANO, G. MELE, et al. 2003. Nuclear factor -B is activated in small intestinal mucosa of celiac patients. J. Mol. Med. 81: 373-379.
52. NIKULINA, M., C. HABICH, S.B. FLOHE, et al. 2004. Wheat gluten causes dendritic cell maturation and chemokine secretion. J. Immunol. 173: 1925-1933.